| Literature DB >> 26058448 |
Michał Antoszczak1, Greta Klejborowska1, Monika Kruszyk1, Ewa Maj2, Joanna Wietrzyk2, Adam Huczyński1.
Abstract
Aiming at development of multitarget drugs for the anticancer treatment, new silybin (SIL) conjugates with salinomycin (SAL) and monensin (MON) were synthesized, in mild esterification conditions, and their antiproliferative activity was studied. The conjugates obtained exhibit anticancer activity against HepG2, LoVo and LoVo/DX cancer cell lines. Moreover, MON-SIL conjugate exhibits higher anticancer potential and better selectivity than the corresponding SAL-SIL conjugate.Entities:
Keywords: anticancer activity; molecular hybrids; natural products; polyether antibiotics; silibinin
Mesh:
Substances:
Year: 2015 PMID: 26058448 DOI: 10.1111/cbdd.12602
Source DB: PubMed Journal: Chem Biol Drug Des ISSN: 1747-0277 Impact factor: 2.817